Department of Cellular and Molecular Biology, Faculty of Sciences and Advanced Technology in Biology, University of Science and Culture, Tehran, Iran.
Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Pathol Res Pract. 2024 Nov;263:155615. doi: 10.1016/j.prp.2024.155615. Epub 2024 Oct 1.
Early detection followed by efficient treatment still remain a considerable challenge for osteosarcoma (OS), indicating the importance of emerging innovative diagnostic methods. Circulating miRNAs offer a promising and non-invasive approach to assess the OS molecular landscapes. This study utilized RNAseq data from OS plasma miRNA expression profiles (PRJEB30542) and PCR Array data (GSE65071) from GEO and ENA databases. In total, 43 miRNAs demonstrated significant differential expression in OS samples of training dataset. A diagnostic model, including hsa-miR-30a-5p, hsa-miR-556-3p, hsa-miR-200a-3p, and hsa-miR-582-5p was identified through multivariate logistic regression analysis and demonstrated significant efficacy in differentiating OS patients from healthy controls in the validation group (AUC: 0.917, sensitivity: 1, specificity: 0.85). The result of target gene prediction and functional enrichment analyses revealed significant associations with terms such as epithelial morphogenesis, P53 and Wnt signaling pathways, and neoplasm metastasis. Further bioinformatics-based evaluations showed that the down-regulation of these miRNAs significantly correlates with poor prognosis and lower survival rate in OS patients and propose their tumor suppressor function in pathogenesis of OS. Furthermore, the study developed a miRNA-mRNA subnetwork that connects these miRNAs to the P53 and Wnt signaling pathways, which are critical pathways with oncogenic effects on OS progression. This comprehensive approach not only presents a promising diagnostic model but also proposes potential molecular markers for OS early diagnosis, making prognosis, and targeted therapy. The identified miRNA-mRNA functional axis holds promise as a valuable resource for further research in understanding OS pathogenesis and establishing therapeutic modalities.
早期检测和有效治疗仍然是骨肉瘤(OS)的一个重大挑战,这表明新兴创新诊断方法的重要性。循环 miRNA 提供了一种有前途的非侵入性方法来评估 OS 的分子图谱。本研究利用了 OS 血浆 miRNA 表达谱的 RNAseq 数据(PRJEB30542)和 GEO 和 ENA 数据库中的 PCR 阵列数据(GSE65071)。在训练数据集的 OS 样本中,共有 43 个 miRNA 表现出显著的差异表达。通过多元逻辑回归分析确定了一个包括 hsa-miR-30a-5p、hsa-miR-556-3p、hsa-miR-200a-3p 和 hsa-miR-582-5p 的诊断模型,该模型在验证组中显示出区分 OS 患者和健康对照的显著疗效(AUC:0.917,灵敏度:1,特异性:0.85)。靶基因预测和功能富集分析的结果显示与上皮形态发生、P53 和 Wnt 信号通路以及肿瘤转移等术语存在显著关联。进一步基于生物信息学的评估表明,这些 miRNA 的下调与 OS 患者的预后不良和生存率降低显著相关,并提出了它们在 OS 发病机制中的肿瘤抑制功能。此外,该研究还开发了一个 miRNA-mRNA 子网,将这些 miRNA 与 P53 和 Wnt 信号通路连接起来,这些信号通路对 OS 进展具有致癌作用。这种综合方法不仅提出了一种有前途的诊断模型,还提出了用于 OS 早期诊断、预后和靶向治疗的潜在分子标志物。所鉴定的 miRNA-mRNA 功能轴有望成为进一步研究 OS 发病机制和建立治疗方式的有价值资源。
Int J Clin Oncol. 2019-5-20
Technol Cancer Res Treat. 2020
Biochim Biophys Acta Mol Basis Dis. 2024-10
FEBS Open Bio. 2020-4
Pathol Res Pract. 2019-4-6
Cancer Gene Ther. 2025-8-16
Life (Basel). 2025-6-12